# Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial of the Combined Lysis of Thrombus With Ultrasound and Systemic Tissue Plasminogen Activator (tPA) for Emergent Revascularization in Acute Ischemic Stroke

Study · id `cardio:ct-nct01098981` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01098981](<https://clinicaltrials.gov/study/NCT01098981>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01098981

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 675 participants.

## Technical summary

Registry record NCT01098981. Randomized; triple masking; primary purpose treatment. Start 2013-05 (registry gives no type); primary completion 2015-04 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 675 participants (enrolled count; ClinicalTrials.gov record NCT01098981, source copy `cardio:ctgov-nct01098981-2015-04-07`, retrieved 2026-10-26)
- Start date: 2013-05 (registry gives no type) (ClinicalTrials.gov record NCT01098981, source copy `cardio:ctgov-nct01098981-2015-04-07`, retrieved 2026-10-26)
- Primary completion: 2015-04 (actual) (ClinicalTrials.gov record NCT01098981, source copy `cardio:ctgov-nct01098981-2015-04-07`, retrieved 2026-10-26)
- Completion: 2015-04 (actual) (ClinicalTrials.gov record NCT01098981, source copy `cardio:ctgov-nct01098981-2015-04-07`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT01098981, source copy `cardio:ctgov-nct01098981-2015-04-07`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01098981-2015-04-07`, retrieved 2026-10-26)

## The registry's words

- Brief title: Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial of the Combined Lysis of Thrombus With Ultrasound and Systemic Tissue Plasminogen Activator (tPA) for Emergent Revascularization in Acute Ischemic Stroke
- Acronym: CLOTBUST-ER
- Condition: Acute Ischemic Stroke
- Intervention (Device): Transcranial ultrasound as an adjunctive therapy to tPA
- Intervention (Drug): Standard of care tPA therapy for acute ischemic stroke
- Lead sponsor: Cerevast Therapeutics, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Combined lysis of thrombus with ultrasound and systemic tissue plasminogen activator for emergent revascularization in acute ischemic stroke (CLOTBUST-ER): design and methodology of a multinational phase 3 trial (`cardio:pubmed-26120902`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Safety and efficacy of sonothrombolysis for acute ischaemic stroke: a multicentre, double-blind, phase 3, randomised controlled trial (`cardio:pubmed-30878103`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: cbdee610c22b0c58ee2777f8cc50420278354cb5bcec68222034649328514690
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
